Clinical Genetics · New Brunswick, NJ
NPI
1851403539
Since 2006
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
254 Easton Ave
New Brunswick, NJ, 08901
Phone (732) 745-6659
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.0M
82 prescriptions
Company payments, 2025
$20.62
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Debra-Lynn E Day-Salvatore prescribed most often to Medicare patients was Cerdelga (Eliglustat Tartrate), with 23 prescriptions and refills. In total Debra-Lynn E Day-Salvatore wrote 82 Medicare prescriptions that cost $1.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-26.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Cerdelga Eliglustat Tartrate | 23 | 23 | Under 11 | $725K |
| Sapropterin Dihydrochloride Generic | 21 | 21 | Under 11 | $78K |
| Cystadane Betaine | 15 | 15 | Under 11 | $39K |
| Palynziq Pegvaliase-Pqpz | 12 | 12 | Under 11 | $140K |
Brand drugs: 51 claims; generic drugs: 31 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Debra-Lynn E Day-Salvatore $20.62 ($20.62 in general payments such as food, travel and fees) from 2 companies. The largest payer was Genzyme Corporation with $20.62.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 1 | $20.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.